CAS: 3251-96-5; Manganese(Ii) Formate
该化合物是一种无机化合物,配有Mn(HCOO)22H2O的配方.它看起来是粉色粉色至白色晶状固体,其特点是水中的溶解性,便于在各种应用中使用,包括作为锰催化剂合成和锰盐生产中的前体;该化合物含有+2氧化状态中的锰,这对它与其他化学物种的再活动与互动具有重要意义;该二氢形式表明它含有每个配方体的两个水分子,有助于其稳定性并影响其物理特性.一般认为,对二氢酸锰的混合物具有低毒性,但与许多锰化合物一样,应当谨慎处理,以避免吸入或摄入.该化合物的应用范围扩大到农业等领域,可以用作微量营养素,以及各种工业过程.适当的储存条件对于保持其完整性并防止其退化至关重要.
- 英文名称Manganese(Ii) Formate
- 中文名称二水甲酸锰(II)
- IUPAC名称manganese(II) formate
- 其它别名Manganese(Ii) Formate; Manganese Formate; Formic Acid Manganese (Ii) Salt; Manganese Diformate; Bisformic Acid Manganese(Ii) Salt; Diformic Acid Manganese(Ii) Salt; Manganese(Ii) Diformate; Formic Acid, Manganese(2+) Salt (2:1)
- CAS编号3251-96-5
- MFCD编号:MFCD00050832
- EINECS号:221-842-7
- 分子式:C2H2MnO4分子量:144.97
- 产品CID: 1316234
- 产品分类有机原料 → 羧酸类化合物及衍生物 → 羧酸酯及其衍生物的盐
- 相似结构搜索
- 产品信息参考
; - InChIKey: BHVPEUGTPDJECS-UHFFFAOYSA-L
- InChI=1S/2CH2O2.Mn/c2*2-1-3;/h2*1H,(H,2,3);/q;;+2/p-2
- 计算化学: 氢键受体数4.0氢键供体数*可旋转键数*
物理性质
MSDS等安全信息
欧盟法规
ECHA物质ECHA物质C&L通报REACH预注册合成工艺路线路线简述
海关参考信息
- 2905110000-甲醇
2912110000-甲醛
2915110000-甲酸 - 💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
- 详情请参考：📖 海关编码查询和海关进出口税则
专利信息
专利号:US-9388045-B2
优先权日:2013-05-08
标 题:Synthesis and characterization of lithium nickel manganese cobalt phosphorous oxide
发明人：CHANG CHUN-CHIEH; CHANG TSUN YU
权利人:CHANGS ASCENDING ENTPR CO LTD; CHANGS ASCENDING ENTPR CO
摘要:Disclosed herein are certain embodiments of a novel chemical synthesis route for lithium ion battery applications. Accordingly, various embodiments are focused on the synthesis of a new active material using NMC (Lithium Nickel Manganese Cobalt Oxide) as the precursor for a phosphate material having a layered crystal structure. Partial phosphate generation in the layer structured material stabilizes the material while maintaining the large capacity nature of the layer structured material.
专利号:US-2025197439-A1
优先权日:2022-03-18
标 题:Decarboxylative acetoxylation using mn(ii) or mn(iii) reagent for synthesis of 4'-acetoxy-nucleoside and use thereof for synthesis of corresponding 4'-(dimethoxyphosphoryl)methoxy-nucleotide
发明人：VAGLE KURT EDRIC; BHADURI SAYANTAN; YANG GUOHAN
权利人:DICERNA PHARMACEUTICALS INC
摘要:The present invention relates to the preparation of nucleic acids, nucleosides, nucleotides, and analogues thereof useful as potent and stable RNA interference agents. The present invention provides improved yields and avoids the use of lead tetraacetate for decarboxylative acetylation which decreases the overall cost of production by removing the need for lead remediation and offers a significant reduction in the environmental costs in production.
专利号:EP-4493568-A1
优先权日:2022-03-18
标 题 :Decarboxylative acetoxylation using mn(ii) or mn(iii) reagent for synthesis of 4'-acetoxy- nucleoside and use thereof for synthesis of corresponding 4'-(dimethoxyphosphoryl)methoxy- nucleotide
专利号:WO-2023177866-A1
优先权日:2022-03-18
标题 :Decarboxylative acetoxylation using mn(ii) or mn(iii) reagent for synthesis of 4'-acetoxy- nucleoside and use thereof for synthesis of corresponding 4'-(dimethoxyphosphoryl)methoxy- nucleotide
专利号:CN-118891266-A
优先权日:2022-03-18
标题:Decarboxylation acetoxylation using Mn (II) or Mn (III) reagent for synthesis of 4 '-acetoxy-nucleoside and use thereof for synthesis of corresponding 4' - (dimethoxyphosphoryl) methoxy-nucleotide
专利号:US-2023163351-A1
优先权日:2021-11-25
标题:Large-scale synthesis of powders of solid-state electrolyte material particles for solid-state batteries, systems and methods thereof
